Greenberg Traurig advises life sciences and medical tech clients on a range of transactional, regulatory, IP, and litigation matters. The firm regularly represents clients before administrative and regulatory agencies and frequently advises on FDA-related issues. Its work spans corporate transactions, regulatory compliance, and dispute resolution for companies operating in the healthcare and life sciences sectors. In Boston, David Dykeman, co-chair of the global life sciences and medical technology group, focuses on IP protection and related commercial strategy for medical device and life sciences clients. Atlanta-based Wayne Elowe, also co-chair of the group, advises multinational companies and investors on cross-border corporate and transactional matters in the life sciences and medical tech industries. In Washington, DC, Chia-Feng Lu represents tech companies in regulatory and legislative processes, while Melissa Hunter-Ensor, co-chair of the global patents and innovation strategies group and working from Boston, advises pharma, biotech, diagnostics, agricultural, and medical device companies on IP and commercial matters.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Testimonials
Collated independently by Legal 500 research team.
‘Everyone from Greenberg Traurig LLP has been courteous and professional and deliver high-quality work. Their billing usually accurately reflects the work and hours of work.’
‘Mr. Chia-Feng Lu is my lead counsel from Greenberg Traurig LLP. He provides advice to us based on his vast knowledge and experience in healthcare business, especially about pharmaceutical licensing and transactions, which is very reassuring. He works in a very proactive and collaborative manor. We could always count on him and his staff for what we need in a timely manner.’
‘This practice is distinguished by its deep understanding of the medical device industry and its ability to integrate regulatory, corporate, IP, and commercial considerations into a single, coherent legal strategy.'
'I have worked with David Dykeman and his team for the better part of 25 years, across multiple companies, and that continuity reflects both the quality of their work and the level of trust they consistently earn.'
'The team’s strength has been its practical command of the full medical device lifecycle.'
'Advice is grounded in how devices are actually developed, validated, regulated, manufactured, and commercialized.'
Work highlights
Provided IP counselling during preparing and negotiations of an Acquisition Agreement.
Advised OPKO Health Inc., in negotiating an agreement to sell select assets of its wholly owned subsidiary, BioReference Health, to Labcorp.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Wayne Elowe
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Chia-Feng Lu
Practice head
David Dykeman; Wayne Elowe
Other key lawyers
Chia-Feng Lu; Melissa Hunter-Ensor